Related Experiment Video
Updated: Aug 9, 2026
09:33
Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
Published on: June 2, 2018
Developmental and metabolic disorders of the pancreas
Markus M Lerch1, Martin Zenker, Stefan Turi
1Department of Gastroenterology, Endocrinology and Nutrition, Ernst-Moritz-Arndt-University, Friedrich-Loeffler-Strasse 23A, Greifswald 17485, Germany. lerch@uni-greifswald.de
Endocrinology and Metabolism Clinics of North America
|April 25, 2006
Summary
This review covers pancreatic developmental and metabolic disorders. It details how abnormalities in embryonic development or genetic changes can impact pancreatic function and increase risks for diseases like pancreatitis and diabetes.
Area of Science:
- Developmental Biology
- Endocrinology
- Genetics
Background:
- The pancreas is crucial for both exocrine and endocrine functions.
- Pancreatic development originates from endoderm during early embryogenesis.
- Disorders affecting the pancreas can stem from developmental anomalies or genetic factors.
Purpose of the Study:
- To review developmental disorders impacting pancreatic anatomy and function.
- To discuss metabolic disorders affecting the pancreas.
- To highlight genetic influences on pancreatic health and disease risk.
Main Methods:
- Literature review of developmental and metabolic disorders of the pancreas.
- Synthesis of information on embryogenesis and genetic contributions.
- Analysis of conditions leading to anatomic and metabolic abnormalities.
Main Results:
- Developmental disorders can cause structural pancreatic abnormalities.
- Genetic factors contribute to metabolic pancreatic diseases.
- Certain disorders increase the risk of pancreatitis and pancreatic diabetes.
Conclusions:
- Understanding pancreatic development is key to identifying congenital disorders.
- Metabolic and genetic factors significantly influence pancreatic endocrine and exocrine function.
- This review consolidates knowledge on diverse pancreatic disorders for clinical and research insight.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.